Latest Filings

Issuer Activity

Insider Overview :: Verisante Technology, Inc. (V:VRS) [?]
Business Focus: Advanced Medical Equipment & Technology Share on StockTwits
Recent Price for VRS
CAD 0.185 0.00 (0.00%)
TSXV Delayed 15 minutes
Apr 22 Close
1-Day High 52-Week High P/E 1-Day Volume Mkt Cap ($Mil)
N/A 0.520 N/A N/A 15.11
1-Day Low 52-Week Low Yield Avg. Volume  
N/A 0.165 0.0% 65,832  
Log in or sign up for a free account to add this stock to your watch list.

Holdings trends & enhanced charts available in PDF report. Click here for details »
Latest 10 SEDI filings (by transaction date) for VRS within the last 6 months [?]
Amended Filing
As of 11:59pm ET April 22nd, 2014
Filing
Date
Transaction
Date
Insider Name Ownership
Type
Securities Nature of transaction # or value acquired or disposed of Price
No SEDI filings within the past 6 months or filings data currently unavailable.
Sign up for an account or login above to see all SEDI filings within the past 6 months.
Latest 10 SEDI filings (by filing date) for VRS within the last 6 months [?]
Amended Filing
As of 11:59pm ET April 22nd, 2014
Filing
Date
Transaction
Date
Insider Name Ownership
Type
Securities Nature of transaction # or value acquired or disposed of Price
No SEDI filings within the past 6 months or filings data currently unavailable.
Sign up for an account or login above to see all SEDI filings within the past 6 months.
Sign up for an account or login above to see the past 6 months of SEDI filings sorted by insider.
No Markers (TSX Insider Summaries) for VRS on April 22, 2014 [?]
To view marker data for the past week, sign up for an account or log in above.
To view more history, sign up for an account at inkresearch.com
Sector:  Healthcare Industry:  Advanced Medical Equipment & Technology
 
See Regulatory Filings on SEDAR
Key People
Thomas A. Braun
President, Chief Executive Officer, Chief Business Development Officer, Director
Anna Trinh
Chief Financial Officer, Vice President - Administration, Corporate Counsel, Secretary
 
Company Contact
Address: Suite 306, 2309 West 41st Avenue
VANCOUVER BC V6M 2A3
Tel: N/A
Website: www.verisante.com
IR: www.verisante.com/invest
Business Overview
Verisante Technology, Inc. is a medical device company. The Company is engaged in commercializing systems for the early detection of cancer. The Company's product portfolios include Verisante Aura and Verisante Core. Verisante Aura is a non-invasive Raman spectroscopy system designed to aid medical professionals in the detection of skin cancer. The system provides valuable information by identifying spectral changes associated with the biochemistry of skin cancer cells in less than a second; providing immediate results. The Verisante Core series utilizes the platform technology behind the Verisante Aura for the early detection of other cancers including lung, colon and cervical, using an endoscopic attachment.
Financial Overview
For the nine months ended 30 September 2013, Verisante Technology Inc revenues increased from C$0K to C$853K. Net loss increased 42% to C$3.1M. Revenues reflect an increase in demand for the Company's products and services due to favorable market conditions. Higher net loss reflects Amortization increase of 57% to C$784K (expense), Research and development increase from C$0K to C$63K (expense).
Employees: 8 as of Mar 31, 2009
Reporting Currency: Canadian Dollars
Enterprise value: $13.47M as of Sep 30, 2013
Annual revenue (TTM): $0.85M as of Sep 30, 2013
EBITDA (TTM): -$3.21M as of Sep 30, 2013
Net annual income (TTM): -$4.42M as of Sep 30, 2013
Free cash flow (TTM): -$3.89M as of Sep 30, 2013
Net Debt Last Fiscal Year: N/A
Shares outstanding: 81,698,117 as of Mar 19, 2014
TTM: Trailing Twelve Months
EBITDA: Earnings Before Interest, Taxes, Depreciation, & Amortization
Competitors with Recent Insider Filings
IMRIS (T:IM)
Zecotek Photonics (V:ZMS)
Biosign Technologies (V:BIO)
 
Verisante Technology, Inc. Insider Report Only $20.00